Viewing Study NCT05597306


Ignite Creation Date: 2025-12-26 @ 2:38 PM
Ignite Modification Date: 2026-03-06 @ 6:03 PM
Study NCT ID: NCT05597306
Status: SUSPENDED
Last Update Posted: 2024-12-17
First Post: 2022-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venetoclax and Bomedemstat in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Terrence J Bradley, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Refractory Acute Myeloid Leukemia View
None Acute Myeloid Leukemia, in Relapse View
Keywords: